4F3-38652-57492 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-04
Dose 1 — Pfizer-BioNTech
2021-01-25
Registered in v-safe
2021-01-25
Dose 2 — Pfizer-BioNTech
2021-01-25
Survey response — day 0, dose 2
MedDRA: Swollen tongue — Feeling: Fair · Site: Pain, Itching · Rash, not including the immediate area around the injection site

Free text: Fat tongue 10 min post injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-07-26
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-25
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-04	Pfizer-BioNTech
2	2021-01-25	Pfizer-BioNTech

Free text

Release 2 — day 0, dose 2

2021-01-25

Systemic reaction (other): Fat tongue 10 min post injection

Release 11 — 12 months, dose 2

2022-01-25

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pregnancy	·	·	✓
SRO	Swollen tongue	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release